Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effects of Escitalopram and Memantine on Pattern Separation in Major Depressive Disorder

NCT07139834 is registered in ClinicalTrials.gov with Jeffrey Miller as lead sponsor.

NCT NCT07139834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07139834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effects of Escitalopram and Memantine on Pattern Separation in Major Depressive Disorder
Lead sponsor
Jeffrey Miller
Phase
Phase 1
Overall status
Recruiting
Start date
June 1, 2026
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)